메뉴 건너뛰기





Volumn 332, Issue 6026, 2011, Pages 159-160

First specific drugs raise hopes for hepatitis C

(1)  Enserink, Martin a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALISPORIVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; BOCEPREVIR; CYCLOPHILIN A; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; PEGINTERFERON ALPHA; PROTEINASE; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE INHIBITOR; TELAPREVIR; VIRUS PROTEIN; DRUG DERIVATIVE; N (3 AMINO 1 (CYCLOBUTYLMETHYL) 2,3 DIOXOPROPYL) 3 (2 ((((1,1 DIMETHYLETHYL)AMINO)CARBONYL)AMINO) 3,3 DIMETHYL 1 OXOBUTYL) 6,6 DIMETHYL 3 AZABICYCLO(3.1.0)HEXAN 2 CARBOXAMIDE; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; NS3 PROTEIN, HEPATITIS C VIRUS; NS4 PROTEIN, HEPATITIS C VIRUS; OLIGOPEPTIDE; PROLINE;

EID: 79953831881     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.332.6026.159     Document Type: Short Survey
Times cited : (11)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.